108776 ⎘
Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor; Animal cells or tissues; Human cells or tissues; Vertebrate cells; Cells from the blood or the immune system Macrophages, e.g. Kuepfer cells in the liver; Monocytes
Induced pluripotent stem cells produced from dendritic cells
#302Method for obtaining microglia from pluripotent stem cells
#303Macrophage cell therapy to treat orthopedic injury
#304Methods for generating macrophages with enhanced cancer phagocytosis
#305Anti-ROBO1 CAR-T cell, and preparation and application thereof
#306Use of PLA2G5-deficient suppressive macrophages in suppression of inflammation
#307ALZHEIMER'S DISEASE EARLY DIAGNOSIS AND/OR PROGNOSIS IN CIRCULATING IMMUNE CELLS BASED ON HEPARAN SULFATES AND/OR OF HEPARAN SULFATE SULFOTRANSFERASES
#308Nucleic acid stabilization reagent, kits, and methods of use thereof
#309Treatment and diagnosis of inflammatory disorders
#310Development of dual whole cell-based vaccine against pancreatic cancer
#311Derivation of human microglia from pluripotent stem cells
#312Cell Line of M2c Macrophage and Its Applications
#313METHODS FOR EXPANDING A POPULATION OF ALVEOLAR MACROPHAGES IN A LONG TERM CULTURE
#314Use of anti-CD47 agents to enhance immunization
#315Transgenic macrophages, chimeric antigen receptors, and associated methods
#316METHODS AND COMPOSITIONS FOR MODIFYING MACROPHAGE POLARIZATION INTO PRO-INFLAMMATORY CELLS TO TREAT CANCER
#317Composition having tissue-repairing activity, and use therefor
#318Generation of therapeutic cells using extracellular components of target organs
#319GENERATION OF HUMAN MACROPHAGES IN IMMUNODEFICIENT NON-HUMAN HOSTS
#320COMPOSITIONS HAVING ANTI-FUGETACTIC PROPERTIES FOR TREATMENT OF CANCER
#321Modified monocytes/macrophage expressing chimeric antigen receptors and uses thereof
#322Therapeutic methods involving modulating inflammasome activation of myeloid-derived suppressor cells
#323Three-dimensional co-culture method for adipocytes and macrophages
#324Genetically modified human cell with a corrected mutant sickle cell mutation
#325Methods for obtaining regulatory T cells and uses thereof
#326Immortalized porcine alveolar macrophage
#327Methods of reducing extravasation of inflammatory cells
#328Compositions and methods for reprogramming adult cells through the stemness of a platelet rich fraction of blood containing platelet-like cells in humans
#329ANTI-INFLAMMATORY AGENTS
#330METHODS AND ASSAYS RELATING TO MACROPHAGE DIFFERENTIATION
#331Use of atpenin to activate innate immunity
#332Cell therapy with polarized macrophages for tissue regeneration
#333Oncolytic herpes simplex virus infected cells
#334Optical-quality surface that imparts spatial control of macrophage fusion
#335PCI method for generating immune respose to antigenic molecule using checkpoint inhibitor and TLR3 ligand
#336Methods of mediating macrophage phenotypes
#337SURFACE-MODIFIED MACROPHAGES FOR CELL-BASED DELIVERY
#338Methods for diagnosing and reducing incidences of cardiac allograft rejection
#339Self-aligned fibrous scaffolds for automechanoinduction of cell cultures
#340Method of differentiating human pluripotent stem cells into primitive macrophages
#341Macrophages eat cancer cells using their own calreticulin as a guide
#342CELL CULTURE SUBSTRATE FOR TRAIT INDUCTION CONTROL OF MACROPHAGE AND METHOD OF CONTROLLING TRAIT OF MACROPHAGE
#343TRAIT INDUCTION METHOD OF UNDIFFERENTIATED CELLS
#344CD11 B[low] MACROPHAGES AND CONDITIONED MEDIA THEREOF FOR TREATING CANCER AND/OR FIBROSIS
#345Mammalian alveolar macrophages derived from pluripotent cells
#346Modulation of stimulatory and non-stimulatory myeloid cells
#347METHOD FOR THE CANCER TREATMENT AND PREVENTION OF METASTATIC DISEASE
#348Methods and compositions for modulating peripheral immune function
#349Compositions And Methods For Treating Tumors And Immune Based Inflammatory Diseases
#350Polypeptides, cells, and methods involving engineered CD16
#351Macrophage CAR (MOTO-CAR) in immunotherapy
#352Method For Introducing Exogenous Mitochondria Into A Mammalian Cell
#353Compositions and methods for selective phagocytosis of human cancer cells
#354CHIMERIC ANTIGEN RECEPTOR DENDRITIC CELL (CAR-DC) FOR TREATMENT OF CANCER
#355METHODS RESPECTIVELY FOR PRODUCING MESODERMAL CELLS AND HEMATOPOIETIC CELLS
#356Administration of Angiocidin for the Treatment of Cancer
#357Method for obtaining globally activated monocytes
#358Culture medium for cellular immunotherapy
#359BIOTIN-AVIDIN CONTROLLED DELIVERY SYSTEMS
#360β-glucan methods and compositions that affect the tumor microenvironment
#361Genetic engineering of macrophages for immunotherapy
#362GALECTIN-9-SECRETING CELL, AND PRODUCTION METHOD AND USE OF THE SAME
#363Method of producing microglial cells
#364Immortalized porcine alveolar macrophage
#365REGULATORY MACROPHAGES AS A CELL-BASED IMMUNOMODULATORY THERAPY IN PULMONARY HYPERTENSION AND RIGHT VENTRICULAR DYSFUNCTION
#366A METHOD OF PRODUCING EXOSOMES
#367STIMULATION OF IMMUNITY TO ENDOTHELIAL CELLS, ENDOTHELIAL-LIKE CELLS, AND INTRATUMOR VASCULAR CHANNELS DERIVED FROM TUMOR TISSUE
#368USE OF INTERLEUKIN 10 MRNA TRANSFECTED MACROPHAGES IN ANTI-INFLAMMATORY THERAPIES
#369Derivation of human microglia from pluripotent stem cells
#370Human monocyte sub-population for treatment of eye diseases and disorders
#371Methods of treating biofilm infections comprising administering inhibitors of myeloid-derived suppressor cells
#372Use of anti-CD47 agents to enhance immunization
#373METHODS AND SYSTEMS FOR COLLECTING MONONUCLEAR CELLS
#374Tumor Targeted Sickle Erythroid Precursors, Progenitors and Hematopoietic Stem Cells, Induced Pluripotent Stem Cells, Microparticles and Liposomes for Treatment of Cancer
#375Inhibition of choroidal neovascularization
#376Macrophage identification agent, and identification method, sorting method, evaluation method, screening method and kit using the macrophage identifier agent
#377Composition having tissue-repairing activity, and use therefor
#378ACTIVATED LEUKOCYTE COMPOSITION AND USES FOR WOUND HEALING
#379CD11 B[low] macrophages and conditioned media thereof for treating cancer and/or fibrosis
#380ANTI-INFLAMMATORY AGENTS
#381Method for in vitro proliferation of cell population containing cells suitable for treatment of ischemic disease
#382Method for obtaining monocytes or NK cells
#383Methods and Compositions for Treating or Diagnosing Melanoma
#384Compositions and methods for gene therapy
#385Methods of mediating macrophage phenotypes
#386Method for increasing the proportion of animal cells secreting galectin-9
#387METHOD FOR GENERATION OF CONDITIONALLY IMMORTALIZED HEMATOPOIETIC PROGENITOR CELL LINES WITH MULTIPLE LINEAGE POTENTIAL
#388Cell Compositions and Methods of Using Same
#389HIGH-RESOLUTION TRANSCRIPTOME OF HUMAN MACROPHAGES
#390Method of preparing apoptotic monocytes
#391Proliferating agent for monocyte, culture medium for proliferating monocyte, method for producing monocyte, method for producing dendritic cell, and method for producing dendritic cell vaccine
#392Immunomodulatory conjugates
#393Ischemic tissue cell therapy
#394Human monocyte sub-population for treatment of central nervous system injury
#395Compositions and methods for modulating myeloid derived suppressor cells
#396Methods of generating hyper INOS expressing cells and uses thereof
#397Methods and compositions for modulating peripheral immune function
#398ERYTHROPOIETIC ROLE OF RESIDENT MACROPHAGES IN HEMATOPOIETIC ORGANS
#399Composition for prevention or treatment of ischemic cardiac disease, comprising inhibitor against age-albumin synthesis or release of mononuclear phagocyte system cells as active ingredient
#400Macrophage hazardous material detection
#401Method for expanding monocytes
#402CD14+ Cell Compositions and Methods of Using Same
#403MONONUCLEAR CELL PREPARATION MATERIAL AND MONONUCLEAR CELL PREPARATION METHOD USING SAME
#404Therapy and method for intratumorally introducing cytotoxic T lymphocyte and/or NKT cell with anti-TNF and/or anti-IL-10
#405Use of interleukin 10 mRNA transfected macrophages in anti-inflammatory therapies
#406Mixed cell populations for tissue repair and separation technique for cell processing
#407Method of producing myeloid blood cells
#408Derivation of hematopoietic cells from adult mesenchymal stem cells
#409SUBSTITUTE THERAPY FOR GLUCOCORTICOIDS
#410SEPARATING MATERIAL AND METHOD FOR COLLECTING CELL OR THE LIKE USING THE SAME
#411INHIBITION OF CHOROIDAL NEOVASCULARIZATION
#412Efficient proliferation method for a kupffer cell and use thereof
#413SEPARATING MATERIAL AND METHOD FOR COLLECTING CELL OR THE LIKE USING THE SAME
#414Method for inducing extended self-renewal of functionally differentiated somatic cells
#415Method of making macrophage expressing an antibody directed against β-amyloid
#416Method for expanding monocytes
#417Activated leukocyte composition and uses for wound healing
#418Isolated monocyte populations and related therapeutic applications
#419Administration of angiocidin for the treatment of leukemia
#420Ischemic tissue cell therapy
#421Methods of reducing extravasation of inflammatory cells
#422Stem cell for therapeutic use which is derived from human monocyte, and method for inducing same
#423Mixed cell populations for tissue repair and separation technique for cell processing
#424Mixed cell populations for tissue repair and separation technique for cell processing
#425Monocyte-Derived Stem Cells (MDSC) and Methods of Use Thereof
#426Anti-inflammatory macrophages and uses thereof
#427Hematopoietic Fingerprints: Methods of Use
#428HEMATOPOIETIC CELLS THAT EXPRESS MOSC-1
#429Macrophage cell-lines for propagation of porcine reproductive and respiratory syndrome virus
#430Generation of mature myelomonocytic cells through expansion and differentiation of pluripotent stem cell-derived linCD34CD43CD45progenitors
#431METHOD OF USING STROMA CELLS FROM CORD BLOOD TO EXPAND AND ENGRAFT NUCLEATED CELLS FROM CORD BLOOD
#432Method for expanding monocytes
#433METHODS OF PRODUCING PREADIPOCYTES AND INCREASING THE PROLIFERATION OF ADULT ADIPOSE STEM/PROGENITOR CELLS
#434Vaccine comprising monocyte or immature myeloid cells (IMC) which were loaded with the ligand of natural killer T cell and antigen
#435Separating material and method for collecting cell or the like using the same
#436PELCAM-1-related molecules compositions kit of parts and associated methods of use
#437ENDOTHELIAL PROGENITOR CELLS AND METHODS OF USE THEREOF
#438Methods and Compositions for Facilitating Tissue Repair and Diagnosing, Preventing, and Treating Fibrosis
#439Targeted Therapy
#440Preparation of replicating macrophages and use in diagnosis and therapy
#441Methods of promoting hematopoietic and mesenchymal cell proliferation and differentiation
#442Derivation of unlimited quantities of neutrophils or monocyte/dendritic cells
#443Use of Sirnas in Organ Storage/Reperfusion Solutions
#444Compositions and Method for Brain Specific Targeted Delivery of Therapeutic Agents
#445Methods for Isolating Monocytes
#446Mixed cell populations for tissue repair and separation technique for cell processing
#447Monocyte cell
#448Human Stem Cell Materials and Methods
#449METHOD OF INDUCING TOLERANCE TO BETAAP 1-42 AND MYELIN BASIC PROTEIN
#450Peripheral blood mononuclear cells
#451Method and composition for producing a cellular allogeneic vaccine
#452Compositions for immunotherapy and uses thereof
#453Transplant acceptance inducing cells of monocytic origin and their preparation and use
#454Enclosures housing cell-coated supports for treating tumors
#455Autologous self-tolerance inducing cells of monocytic origin and their use in pharmaceutical preparations
#456Method for enriching adherent monocyte populations
#457Immunomodulating compositions, processes for their production and uses therefor
#458PECAM-1-related molecules compositions kit of parts and associated methods of use
#459Method for inducing complete hepatitis c virus (hcv) replication in vitro
#460Rapid generation of activated mononuclear antigen presenting cells from monocytes
#461Human stem cell materials and methods
#462Disease therapy using dying or dead cells
#463Endothelial progenitor cells and methods of use thereof
#464Method and composition for producing a cellular allogeneic vaccine
#465Methods for using the obese gene and its gene product to identify hematopoietic progenitor cells
#466Process for the manufacturing of human mononuclear phagocytic leukocytes
#467Use of discoidin domain receptor 1 (DDR1) and agents that affect the DDR1/collagen pathway
#468Pluripotent cells from monocytes, and methods of making and using pluripotent cells
#469Method for the treatment or diagnosis of human pathologies with disseminated or difficult to access cells or tissues
#470Chimeric antigen receptor dendritic cell (CAR-DC) for treatment of cancer